Researchers from Spain have developed a method that could change the approach to osteoporosis. They modified patients' mesenchymal stem cells by adding a "return address" to the bone marrow.
A phase 1 clinical trial involved ten women over 50 years of age with advanced disease. Each received a single infusion of their own cells enclosed in a special sugar coating.
The results were striking. Over the two years following the procedure, the rate of fragility fractures fell by 94 percent — from an average of eight per year to 0,5.
Bone biopsies taken after four months showed an average increase in bone tissue area of 70 percent. Markers of new bone formation remained elevated for six months.
After two years, patients reported a 34 percent reduction in bone pain and a 30 percent decrease in disability scores.
For now this is a small study, but it provides grounds for further trials. The method is aimed specifically at restoration, not merely at preventing new fractures.

